Please login to the form below

Not currently logged in
Email:
Password:

licensing

This page shows the latest licensing news and features for those working in and with pharma, biotech and healthcare.

MaxCyte gets green light for solid tumour cell therapy

MaxCyte gets green light for solid tumour cell therapy

MaxCyte has two sides to its business, developing its own therapies on one hand and on the other licensing its flow electroporation platform for use by other companies. ... collaborations and licensing deals with academic and industrial partners, which

Latest news

More from news
Approximately 7 fully matching, plus 583 partially matching documents found.

Latest Intelligence

  • Leo has its eyes on the prize Leo has its eyes on the prize

    We will be very active in building partnerships and licensing agreements.

  • No incentive for a cure No incentive for a cure

    proven and from the music industry, where the ‘Spotify approach’of licensing rather than purchasing could be applied to drugs.

  • Deal Watch January 2018

    The companies were already partners having signed a $432m licensing deal in July 2016 for ex-US rights to Cx601 with double digit royalties due on net sales (DW Issue 73). ... Winding back to last February (DW Issue 80), Immunomedics announced a

  • Licensing

    Healthcare terms - Licensing.

  • Accelerating innovation Accelerating innovation

    Meanwhile, 2016 saw a licensing deal with Cabometyx (cabozantinib) from Californian biotech Exelixis and an agreement with 3B Pharmaceuticals to develop novel oncology radiopharmaceuticals. ... Partnering. Oncology naturally features prominently in

More from intelligence
Approximately 5 fully matching, plus 81 partially matching documents found.

Latest appointments

  • Gamida Cell strengthens leadership team Gamida Cell strengthens leadership team

    He has also served as vice president, business and corporate development at Infinity Pharmaceuticals, where he was responsible for the company’s in-licensing, out-licensing and alliance management activities.

  • Neurimmune appoints chief business officer Neurimmune appoints chief business officer

    Dr Buller has an impressive track record in business development and licensing transactions.

  • Ipsen bolsters leadership team Ipsen bolsters leadership team

    Prior to this, she has served as senior vice president, head of global business development at Teva Pharmaceuticals, where she led and executed multiple business development transactions ranging from licensing to

  • Damien McDevitt moves from GSK to Acadia Pharmaceuticals Damien McDevitt moves from GSK to Acadia Pharmaceuticals

    Damien has extensive experience in business development, licensing and strategic partnering, and he has completed dozens of value-creating transactions.

  • Apeiron bolsters management board Apeiron bolsters management board

    With more than 25 years’experience in initial public offerings, mergers and acquisitions, as well as licensing and financial transactions in the chemical, biotech and pharma industries, Llewellyn-Davies most recently

More from appointments
Approximately 0 fully matching, plus 42 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 15 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics